Opioid Withdrawal Syndrome Market is Predicted to Exhibit Remarkable Growth by 2030, Analyzes DelveInsight | Key Companies – Chiesi Farmaceutici, Aphios Corporation, US WorldMeds, and Others

Opioid Withdrawal Syndrome Market is Predicted to Exhibit Remarkable Growth by 2030, Analyzes DelveInsight | Key Companies -  Chiesi Farmaceutici, Aphios Corporation, US WorldMeds, and Others

“Delveinsight Business Research LLP”
DelveInsight’s “Opioid Withdrawal Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Opioid Withdrawal Syndrome Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Opioid Withdrawal Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Opioid Withdrawal Syndrome Market

Opioid Withdrawal Syndrome: An Overview

According to the American Addiction Centers, when the use of opiate drugs are stopped, it may produce several withdrawal symptoms and collectively these symptoms are called Opiate Withdrawal Syndrome (OWS). Opiate withdrawal symptoms may range from mild to severe, depending on how dependent the individual is on an opioid drug. 

According to the survey by Roger et al. (2014), 56.5% of participants accepted that avoiding withdrawal was their primary current reason for use of opioids.

Opioid Withdrawal Syndrome Market Key Facts

  • According to the Centers for Disease Control and Prevention, the opioid prescription rate was 75.6% per 100 people in 2014, which decreases to 58.7% per 100 people in 2017. Some counties had an opioid prescription rate seven times higher than the national average.

  • As per the review by Public Health England that assessed the number of prescriptions issued for five common medicines in England used to treat depression and anxiety, insomnia, and chronic pain. It was found that 13% of the population received a prescription of opioids.

  • According to National Survey on Drug Use and Health, 5.2 million Americans (2.1% of the US population) used prescription opioids non-medically in the past month.

  • The prevalence of OWS is estimated to be the same in both males and females. 

  • In 2017, more than 72,000 Americans died from drug overdoses, including illicit drugs and prescription opioids, a 2-fold increase in a decade. The sharpest increase involved synthetic opioids, primarily fentanyl and fentanyl analogs (similar compounds), with nearly 30,000 overdose deaths, according to the Centers for Disease Control and Prevention.

Opioid Withdrawal Syndrome Market 

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Opioid Withdrawal Syndrome market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Opioid Withdrawal Syndrome market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Get the PDF Sample of the Report:- Opioid Withdrawal Syndrome Therapeutics Market

Opioid Withdrawal Syndrome Epidemiology

The epidemiology section covers insights about the historical and current Opioid Withdrawal Syndrome patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Opioid Withdrawal Syndrome (OWS) Epidemiology Segmentation

  • Total Prevalent Population of OWS

  • Diagnosed and Treatable Prevalent Population of OWS

Opioid Withdrawal Syndrome Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Opioid Withdrawal Syndrome market or expected to get launched in the market during the study period. The analysis covers Opioid Withdrawal Syndrome market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Opioid Withdrawal Syndrome Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Opioid Withdrawal Syndrome Therapeutics Analysis

The available therapeutics treatment options in Opioid Withdrawal Syndrome (OWS) landscape aim to provide symptomatic relief arising due to the opioid withdrawal.  The current clinical pipeline of OWS is weak. Only a few players are working toward the development of therapies for OWS. 

Some of the companies in the Opioid Withdrawal Syndrome (OWS) Market includes:

  • Chiesi Farmaceutici

  • Aphios Corporation

  • US WorldMeds

And many others

Opioid Withdrawal Syndrome (OWS) Therapies covered in the report includes:

  • APH-1501

  • CHF6563

  • Lofexidine

And many more

The present treatment options for Opioid Withdrawal Syndrome (OWS) are very limited. The week clinical pipeline and limitations with the presently available therapies offer a great opportunity for the development of novel therapies.

Get More Detailed Insights into the Emerging Therapies & Key Companies:- https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-market

Table of Content

1. Key Insights

2. Executive Summary 

3. Opioid Withdrawal Syndrome Competitive Intelligence Analysis

4. Opioid Withdrawal Syndrome Market Overview at a Glance

5. Opioid Withdrawal Syndrome Disease Background and Overview

6. Opioid Withdrawal Syndrome Patient Journey

7. Opioid Withdrawal Syndrome Epidemiology and Patient Population

8. Opioid Withdrawal Syndrome Treatment Algorithm, Current Treatment, and Medical Practices

9. Opioid Withdrawal Syndrome Unmet Needs

10. Key Endpoints of Opioid Withdrawal Syndrome Treatment

11. Opioid Withdrawal Syndrome Marketed Products

12. Opioid Withdrawal Syndrome Emerging Therapies

13. Opioid Withdrawal Syndrome Seven Major Market Analysis

14. Attribute Analysis

15. Opioid Withdrawal Syndrome Market Outlook (7 major markets)

16. Opioid Withdrawal Syndrome Access and Reimbursement Overview

17. KOL Views on the Opioid Withdrawal Syndrome Market.

18. Opioid Withdrawal Syndrome Market Drivers

19. Opioid Withdrawal Syndrome Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Request Sample Report here:- https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/